NCT05733715 2026-03-24Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell CarcinomaAbramson Cancer Center at Penn MedicinePhase EARLY_PHASE1 Recruiting30 enrolled
NCT07356466 2026-01-21FUGES032Fujian Medical UniversityPhase EARLY_PHASE1 Enrolling by invitation100 enrolled